Xeris Biopharma Holdings, Inc. (XERS)
10.77
+0.02
(+0.19%)
USD |
NASDAQ |
Oct 30, 09:51
Xeris Biopharma Holdings Market Cap : 1.870B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.866B |
| October 28, 2026 | 1.847B |
| October 27, 2026 | 1.814B |
| October 26, 2026 | 1.772B |
| October 23, 2026 | 1.771B |
| October 22, 2026 | 1.885B |
| October 21, 2026 | 1.872B |
| October 20, 2026 | 1.932B |
| October 19, 2026 | 1.901B |
| October 16, 2026 | 1.790B |
| October 15, 2026 | 1.748B |
| October 14, 2026 | 1.696B |
| October 13, 2026 | 1.771B |
| October 12, 2026 | 1.816B |
| October 09, 2026 | 1.819B |
| October 08, 2026 | 1.769B |
| October 07, 2026 | 1.755B |
| October 06, 2026 | 1.748B |
| October 05, 2026 | 1.758B |
| October 02, 2026 | 1.576B |
| October 01, 2026 | 1.606B |
| September 30, 2026 | 1.660B |
| September 29, 2026 | 1.732B |
| September 28, 2026 | 1.706B |
| September 25, 2026 | 1.580B |
| Date | Value |
|---|---|
| September 24, 2026 | 1.554B |
| September 23, 2026 | 1.503B |
| September 22, 2026 | 1.515B |
| September 21, 2026 | 1.528B |
| September 18, 2026 | 1.423B |
| September 17, 2026 | 1.417B |
| September 16, 2026 | 1.351B |
| September 15, 2026 | 1.300B |
| September 14, 2026 | 1.314B |
| September 11, 2026 | 1.293B |
| September 10, 2026 | 1.331B |
| September 09, 2026 | 1.338B |
| September 08, 2026 | 1.472B |
| September 04, 2026 | 1.481B |
| September 03, 2026 | 1.491B |
| September 02, 2026 | 1.489B |
| September 01, 2026 | 1.463B |
| August 31, 2026 | 1.465B |
| August 28, 2026 | 1.472B |
| August 27, 2026 | 1.493B |
| August 26, 2026 | 1.507B |
| August 25, 2026 | 1.517B |
| August 24, 2026 | 1.517B |
| August 21, 2026 | 1.510B |
| August 20, 2026 | 1.493B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zevra Therapeutics, Inc. | 608.25M |
| ANI Pharmaceuticals, Inc. | 1.687B |
| Corcept Therapeutics, Inc. | 9.077B |
| Veru, Inc. | 37.85M |
| Johnson & Johnson | 670.24B |
Market Cap Related Metrics
| PS Ratio | 5.685 |
| Price to Free Cash Flow | 34.25 |
| Price | 10.77 |
| Earnings Yield | -0.95% |
| Operating PE Ratio | 52.10 |
| Normalized PE Ratio | 482.96 |